Dual stimuli-responsive multi-drug delivery system for the individually controlled release of anti-cancer drugs

Chem Commun (Camb). 2015 Jan 28;51(8):1475-8. doi: 10.1039/c4cc08831j.

Abstract

A dual stimuli-responsive multi-drug delivery system was developed for "cancer cocktail therapy". Upon UV irradiation, microcapsules could rapidly release the small-molecule drugs, and thereafter the macromolecular drugs would be released in the presence of MMP in the tumor cells. This system will find great potential as a novel chemotherapeutic combination for cancer treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Cell Line, Tumor
  • Delayed-Action Preparations
  • Dextrans / administration & dosage
  • Dextrans / chemistry
  • Dextrans / radiation effects
  • Drug Delivery Systems*
  • Endocytosis
  • Fluorescein-5-isothiocyanate / administration & dosage
  • Fluorescein-5-isothiocyanate / chemistry
  • Fluorescein-5-isothiocyanate / radiation effects
  • Humans
  • Matrix Metalloproteinases / chemistry
  • Matrix Metalloproteinases / metabolism*
  • Matrix Metalloproteinases / radiation effects
  • Polymers / chemistry
  • Rhodamines / administration & dosage
  • Rhodamines / chemistry
  • Rhodamines / radiation effects
  • Ultraviolet Rays*
  • alpha-Cyclodextrins / administration & dosage
  • alpha-Cyclodextrins / chemistry
  • alpha-Cyclodextrins / radiation effects

Substances

  • Antineoplastic Agents
  • Delayed-Action Preparations
  • Dextrans
  • Polymers
  • Rhodamines
  • alpha-Cyclodextrins
  • Matrix Metalloproteinases
  • Fluorescein-5-isothiocyanate
  • rhodamine B